CompletedNot Applicable

Prevalence and Predictors of Esophageal Thermal Lesions in High-power-Short-duration Ablation of Atrial Fibrillation

Germany263 participantsStarted 2021-03-01

Plain-language summary

Patients with documented atrial fibrillation who were referred to our clinic for catheter ablation will undergo standard HPSD ablation and subsequent esophagoscopy. After esophagoscopy patients will be followed up for one month in the form of a telephone follow-up. The primary endpoint of the study assessed by esophagoscopy performed on the day after the index catheter ablaton is the incidence of esophageal thermal lesions. Secondary endpoints include: 1. The size of the esophageal thermal lesions. 2. The severity of esophageal thermal lesions.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Atrial fibrillation documented in the 12-lead ECG * Indication for catheter ablation in accordance with currentn ESC guidelines Exclusion Criteria: * Pregnancy * Women of childbearing potential without a negative pregnancy test within 48 hours prior to ablation procedure * Known intracardiac or other thrombi * Contraindication to anticoagulation * Contraindication to esophagoscopy: diseases and deformities of the cervical spine, esophageal varices

What they're measuring

Prevalence of ablation-related esophageal thermal lesions

Timeframe: One day after Catheter ablation

Trial details

NCT IDNCT05709756

SponsorHelios Health Institute GmbH

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-08-01

View on ClinicalTrials.gov More Esophagus Injury trials